Mediwhale

Mediwhale is an AI-powered health diagnostics company that uses non-invasive retina scans to predict cardiovascular and kidney disease risks. Its flagship product, Reti-CVD, provides highly accurate risk assessments using AI algorithms, offering a simple and radiation-free alternative to traditional methods. The company aims to make preventative care more accessible and affordable.

Buy Funded Startups lists

Funding Round: Series A2

Funding Amount: $12M

Date: 25-Sep-2024

Investors: Korea Development Bank (KDB), Woori Venture Partners, IMM Investment, Mirae Asset Securities

Markets: Healthtech, AI, Medical Device, Software

HQ: Seoul, South Korea

Founded: 2016

Website: https://mediwhale.com/

LinkedIn: https://www.linkedin.com/company/mediwhale

Twitter:

Instagram: